Angiotensin-converting enzyme gene polymorphism in North-west Indian children with posterior urethral valves

Published:February 02, 2007DOI:



      To investigate the association of angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and other risk factors with renal scarring in patients with posterior urethral valves (PUV).

      Materials and methods

      Forty consecutive patients from North-west India were treated for PUV in 1997–2004. The patients were divided into group 1 (no renal scarring, n=12) and group 2 (renal scars present, n=28) based on dimercato-succinic acid scans. ACE I/D polymorphism was determined by polymerase chain reaction in PUV patients and unrelated healthy controls (n=100).


      Mean age at presentation was 23.7±37.2 months and mean follow up was 4.8±1.5 years. Preoperative mean serum creatinine levels for group 1 (non-scarred) and group 2 (scarred) were 1.1±1.6 mg/dl and 1.7±1.6 mg/dl, respectively. One year after treatment, the serum creatinine levels had decreased to 0.6±0.1 mg/dl and 0.8±0.3 mg/dl in group 1 and group 2, respectively. ACE genotype distribution in children with PUV was no different from that of controls. The occurrence of D allele was significantly (p=0.04) higher in patients of group 2. Multivariate logistic regression analysis showed that D allele had a significant impact on renal scar formation, introducing a 4.6-fold risk (odds ratio 4.6, 95% confidence interval 1.03–20.38, p=0.04). A highly significant correlation between the occurrence of renal scarring and presence of breakthrough urinary tract infection (odds ratio=7.5, 95% confidence interval 1.60–35.07, p=0.006) and serum creatinine at follow up (odds ratio=0.6, 95% confidence interval 0.47–0.81, p=0.03) was observed. The mean values for glomerular filtration rate (GFR) after 1 year of treatment (p=0.006) and at follow up (p=0.027) were significantly different between the patients with II genotype and ID/DD genotype. Hypertension was observed in 13 patients and proteinuria in nine patients with no significant difference between the patients having II/I D/DD genotypes.


      The presence of D allele is associated with progression of renal scarring and reduced GFR in PUV patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Pediatric Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Parkhouse H.F.
        • Barrat T.M.
        • Dillon M.J.
        • Duffy P.G.
        • Fay J.
        • Ransley P.G.
        • et al.
        Long term outcome of boys with posterior urethral valves.
        Br J Urol. 1988; 62: 59
        • Scott J.E.
        Management of congenital posterior urethral valves.
        Br J Urol. 1985; 57: 71
        • Smith G.H.
        • Duckett J.W.
        • Canning D.A.
        Posterior urethral valves, a cohort with a 20-year follow up.
        J Urol. 1994; 151: 275
        • Harden P.N.
        • O'Kane K.P.
        • Ueda S.
        • Connell J.M.
        • Jardine A.G.
        Association studies, ACE polymorphism and renal disease.
        Nephrol Dial Transplant. 1996; 11: 757-759
        • Hohenfellner K.
        • Wingen A.M.
        • Nauroth O.
        • Wuhl E.
        • Mehls O.
        • Schaefer F.
        Impact of ACE I/D gene polymorphism on congenital renal malformations.
        Pediatr Nephrol. 2001; 16: 356
        • Cambien F.
        • Poirier O.
        • Lecerf L.
        • Evans A.
        • Cambou J.P.
        • Arveiler D.
        • et al.
        Deletion polymorphism in the gene for angiotensin converting enzyme is a potential risk factor for myocardial infarction.
        Nature. 1992; 359: 641
        • Bajpai M.
        • Pratap A.
        • Somitesh C.
        • Tyagi J.
        Angiotensin converting enzyme gene polymorphism in Asian Indian children with congenital uropathies.
        J Urol. 2004; 171: 838-840
        • International Reflux Study Committee
        Medical versus surgical treatment of primary vesicoureteral reflux, a prospective international reflux study in children.
        J Urol. 1981; 125: 277
        • Morris M.C.
        • Allanby C.W.
        • Toseland P.
        • Haycock G.B.
        • Chantler C.
        Evaluation of height/plasma creatinine formula in the measurement of glomerular filtration rate.
        Arch Dis Child. 1982; 57: 611-615
      1. Report of the Second Task Force on blood pressure control in children – 1987. Task Force on Blood Pressure Control in Children. The National Heart, Lung, and Blood Institute, Bethesda, Maryland.
        Pediatrics. 1987; 79: 1-25
        • Gill P.
        • Werrett D.J.
        Exclusion of a man charge with murder by DNA fingerprinting.
        Forensic Sci Int. 1987; 35: 145-148
        • Tiret L.
        • Kee F.
        • Poi Pievol L.
        • Evans A.
        • Cambien F.
        Deletion polymorphism in Ace gene associated with present history of myocardial infarction.
        Lancet. 1993; 341: 991
        • Zee R.Y.
        • Lou Y.K.
        • Griffiths L.R.
        • Morris B.J.
        Association of a polymorphism of the angiotensin I converting enzyme gene with essential hypertension.
        Biochem Biophys Res Commun. 1992; 184: 9
        • Narasimhan K.L.
        • Chowdhary S.K.
        • Kaur B.
        • Mittal B.R.
        • Bhattacharya A.
        Factors affecting renal scarring in posterior urethral valves.
        J Pediatr Urol. 2006; 2: 569-574
        • Yoneda A.
        • Oue T.
        • Puri P.
        Angiotensin converting enzyme genotype distribution in familial vesicoureteric reflux.
        Pediatr Surg Int. 2001; 17: 308
        • al-Eisa A.
        • Haider M.Z.
        • Srivastva B.S.
        Angiotensin converting enzyme gene insertion/deletion polymorphism and renal damage in childhood uropathies.
        Pediatr Int. 2000; 42: 348
        • Brock J.W.
        • Adams M.
        • Hunley T.
        • Wada A.
        • Trusler L.
        • Kon V.
        Potential risk factors associated with progressive renal damage in childhood urological diseases: the role of angiotensin converting enzyme gene polymorphism.
        J Urol. 1997; 158: 1308
        • Ozen S.
        • Alikasifoglu M.
        • Saatci U.
        • Bakkaloglu A.
        • Besbas N.
        • Kara N.
        • et al.
        Implications of certain genetic polymorphism.
        Am J Kidney Dis. 1999; 34: 140
        • Hohenfellner K.
        • Hunley T.E.
        • Brezinska R.
        • Brodhag P.
        • Shyr Y.
        • Brenner W.
        • et al.
        ACE I/D gene polymorphism predict renal damage in congenital uropathies.
        Pediatr Nephrol. 1999; 13: 524
        • Kostic M.
        • Stankovic A.
        • Zirkovic M.
        • Peco-Antic A.
        • Jovanovic O.
        • Alavantic D.
        • et al.
        ACE and AT1 receptor gene polymorphisms and renal scarring in urinary bladder dysfunction.
        Pediatr Nephrol. 2004; 18: 858
        • Rigoli L.
        • Chimenz R.
        • Di Bella C.
        • Cavallaro E.
        • Caruso R.
        • Briuglia S.
        • et al.
        Angiotensin converting enzyme and angiotensin type 2 receptor gene genotype distribution in Italian children with congenital uropathies.
        Pediatr Res. 2004; 56: 988
        • Peruzzi L.
        • Lombardo F.
        • Amore A.
        • Merlini E.
        • Restagno G.
        • Silvestro L.
        • et al.
        Low rennin-angiotensin system activity gene polymorphism and dysplasia associated with posterior urethral valves.
        J Urol. 2005; 174: 713